Johnson & Johnson plans to have 100 million vaccines for Americans by spring, board member says

A J&J board member said “if the clinical trial works out,” the company could significantly increase the nation’s Covid vaccine supply availability.

from Health and Science https://ift.tt/3iLXOdH
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH